On Their Own: Stewart And Feder Persist With Misconduct Inquiries

Walter Stewart and Ned Feder -- forced into new jobs at the National Institutes of Health in April 1993, ending their decade-long careers as self-styled scientific misconduct investigators -- have quietly but persistently continued their inquiries into research wrongdoing. They do so now, however, on their own time and with non-governmental resources. Should Stewart and Feder be reinstated in their former jobs? Many people familiar with their case -- even some who respect the role Stewart and

Written byFranklin Hoke
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Should Stewart and Feder be reinstated in their former jobs? Many people familiar with their case -- even some who respect the role Stewart and Feder have played as scientific whistle-blowers -- voice doubts that their old positions at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) were appropriate ones for their activities.

"They started out as scientists," notes Kenneth J. Ryan, chairman of the federal Commission on Research Integrity-- which heard testimony recently from the two men--and a professor of obstetrics, gynecology, and reproductive biology at Harvard Medical School. "They then became individuals who were interested in the whole matter of scientific integrity and, on their own, created that interest for themselves.

"Whether or not they should be doing that, rather than a division of the [HHS] assistant secretary's office, under ORI, is one of the things the commission may be thinking about and discussing. A ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo